A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma

PURPOSE: Malignant pleural mesothelioma (MPM) is a rare malignancy with a dismal median survival of <12 months with current therapy. Single and combination chemotherapy regimens have shown only modest clinical benefit. In preclinical studies, nitrogen-containing bisphosphonates (zoledronic acid)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamil, Muhammad Omer, Jerome, Mary S, Miley, Deborah, Selander, Katri S, Robert, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476579/
https://www.ncbi.nlm.nih.gov/pubmed/28652837
http://dx.doi.org/10.2147/LCTT.S135802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476579/
https://www.ncbi.nlm.nih.gov/pubmed/28652837
http://dx.doi.org/10.2147/LCTT.S135802

Ejemplares similares